Results 21 to 30 of about 938,469 (386)

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

New England Journal of Medicine, 2018
Background Patients who have had an acute coronary syndrome are at high risk for recurrent ischemic cardiovascular events. We sought to determine whether alirocumab, a human monoclonal antibody to proprotein convertase subtilisin–kexin type 9 (PCSK9 ...
G. Schwartz, G. Steg, M. Szarek, Deepak L. Bhatt, Vera A. Bittner, R. Diaz, Jay M. Edelberg, Shaun G Goodman, C. Hanotin, Robert A Harrington, W. J. Jukema, G. Lecorps, K. Mahaffey, A. Moryusef, R. Pordy, K. Quintero, Matthew T. Roe, W. Sasiela, J. Tamby, P. Tricoci, Harvey D. White, Andreas M. Zeiher   +21 more
semanticscholar   +1 more source

Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome

Cardiovascular Diabetology, 2020
Background The triglyceride-glucose index (TyG index) has been regarded as a reliable alternative marker of insulin resistance and an independent predictor of cardiovascular outcomes.
Le Wang, H. Cong, Jingxia Zhang, Yue-cheng Hu, A. Wei, Yingyi Zhang, Hua Yang, Li-bin Ren, W. Qi, Wen-yu Li, Rui Zhang, Jing-han Xu   +11 more
semanticscholar   +1 more source

Alogliptin after acute coronary syndrome in patients with type 2 diabetes.

New England Journal of Medicine, 2013
BACKGROUND To assess potentially elevated cardiovascular risk related to new antihyperglycemic drugs in patients with type 2 diabetes, regulatory agencies require a comprehensive evaluation of the cardiovascular safety profile of new antidiabetic ...
W. White, C. Cannon, S. Heller, S. Nissen, R. Bergenstal, G. Bakris, Alfonso T. Perez, P. Fleck, C. Mehta, S. Kupfer, Craig A. Wilson, W. Cushman, F. Zannad   +12 more
semanticscholar   +1 more source

Colchicine in Patients with Acute Coronary Syndrome: The Australian COPS Randomized Clinical Trial.

Circulation, 2020
Background: Inflammation plays a crucial role in clinical manifestations and complications of acute coronary syndromes (ACS).
D. Tong, S. Quinn, A. Nasis, C. Hiew, P. Roberts-Thomson, H. Adams, R. Sriamareswaran, N. Htun, W. Wilson, D. Stub, W. van Gaal, L. Howes, N. Collins, A. Yong, R. Bhindi, R. Whitbourn, Astin K Y Lee, C. Hengel, K. Asrress, M. Freeman, J. Amerena, Andrew M. Wilson, J. Layland   +22 more
semanticscholar   +1 more source

Elevated Baseline Serum Fibrinogen: Effect on 2-Year Major Adverse Cardiovascular Events Following Percutaneous Coronary Intervention. [PDF]

, 2017
BackgroundElevated fibrinogen is associated with short-term major adverse cardiovascular events (MACE) after percutaneous coronary intervention, but the relation with late MACE is unknown.Methods and resultsBaseline demographics and 2-year MACE were ...
Ang, Lawrence, Behnamfar, Omid, Lin, Felice, Mahmud, Ehtisham, Palakodeti, Samhita, Patel, Mitul P, Pourdjabbar, Ali, Reeves, Ryan R   +7 more
core   +1 more source

This is not an acute coronary syndrome

Cleveland Clinic Journal of Medicine, 2016
Stress cardiomyopathy—broken heart syndrome—typically affects older women exposed to a stressful life event.
Adam M. May, Jorge A. Brenes-Salazar, Korosh Sharain, Lawrence J. Sinak   +3 more
openaire   +3 more sources

Coronary computed tomography angiography of spontaneous coronary artery dissection: A case report and review of the literature [PDF]

, 2015
Patient: Male, 23 Final Diagnosis: Spontaneous coronary artery dissection Symptoms: Chest discomfort • chest pain Medication: — Clinical Procedure: Coronary computed tomography angiography Specialty: Radiology OBJECTIVE: Rare disease BACKGROUND ...
Bhalla, Sanjeev, Bolton, J. Scott, Maldonado, Jose, Torres-Ayala, Stephanie C.   +3 more
core   +2 more sources

Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation

New England Journal of Medicine, 2019
BACKGROUND Appropriate antithrombotic regimens for patients with atrial fibrillation who have an acute coronary syndrome or have undergone percutaneous coronary intervention (PCI) are unclear. METHODS In an international trial with a two‐by‐two factorial
R. Lopes, G. Heizer, R. Aronson, A. Vora, Tyler Massaro, R. Mehran, S. Goodman, S. Windecker, H. Darius, Jia Li, O. Averkov, Cecilia M. Bahit, O. Berwanger, A. Budaj, Z. Hijazi, A. Parkhomenko, P. Sinnaeve, R. Storey, H. Thiele, D. Vinereanu, C. Granger, J. Alexander   +21 more
semanticscholar   +1 more source

Decline of acute coronary syndrome admissions in Austria since the outbreak of COVID-19: the pandemic response causes cardiac collateral damage

European Heart Journal, 2020
We conducted a nationwide retrospective on the of on the and treatment of elevation myocardial infarction.
B. Metzler, P. Siostrzonek, R. Binder, A. Bauer, S. Reinstadler   +4 more
semanticscholar   +1 more source

Acute myocardial infarction in pregnancy: Current diagnosis and management approaches

Indian Heart Journal, 2019
Acute myocardial infarction during pregnancy is a very uncommon condition; atherosclerotic coronary artery disease is by far the most common cause of an acute coronary syndrome in the general population.
Mohan M. Edupuganti, Vyjayanthi Ganga
doaj   +1 more source